Related Experiment Videos
Induction of lymphokines by tilorone
Archivum Immunologiae Et Therapiae Experimentalis
|January 1, 1977
Summary
Tilorone administration in mice induced both interferon and migration inhibitory factor (MIF) in serum. These factors showed similar kinetics and physicochemical properties, suggesting a link in their production.
Area of Science:
- Immunology
- Pharmacology
Background:
- Tilorone is an immunomodulatory agent.
- Interferon and Migration Inhibitory Factor (MIF) are key immune signaling molecules.
Purpose of the Study:
- To investigate the effects of tilorone on serum interferon and MIF levels in mice.
- To compare the characteristics of tilorone-induced MIF with MIF from in vitro lymphocyte cultures.
Main Methods:
- Oral administration of tilorone to ABD2F1 mice.
- Measurement of serum interferon and MIF activity 16 hours post-administration.
- Kinetic studies of serum factor levels.
- Analysis of physicochemical properties (heat and pH lability, molecular size) of MIF.
Main Results:
- Serum collected 16 hours after tilorone administration exhibited both interferon and MIF activity.
- A close correlation was observed between serum interferon and MIF levels over time.
- Tilorone-induced MIF shared similar physicochemical characteristics with MIF generated in vitro.
Conclusions:
- Tilorone induces the production of both interferon and MIF in vivo.
- The similar properties of tilorone-induced MIF and in vitro MIF suggest a common origin or regulatory mechanism.
- Findings contribute to understanding the production of lymphocytogenic lymphokines.